Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 11/2021

10.07.2021 | Review

Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma

verfasst von: Mohammad Haroon, Paul Sathiadoss, Rebecca M. Hibbert, Satheesh Krishna Jeyaraj, Christopher Lim, Nicola Schieda

Erschienen in: Abdominal Radiology | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten

Abstract

Ablative (percutaneous and stereotactic) thermal and radiotherapy procedures for management of both primary and metastatic renal cell carcinoma are increasing in popularity in clinical practice. Data suggest comparable efficacy with lower cost and morbidity compared to nephrectomy. Ablative therapies may be used alone or in conjunction with surgery or chemotherapy for treatment of primary tumor and metastatic disease. Imaging plays a crucial role in pre-treatment selection and planning of ablation, intra-procedural guidance, evaluation for complications, short- and long-term post-procedural surveillance of disease, and treatment response. Treatment response and disease recurrence may differ considerably after ablation, particularly for stereotactic radiotherapy, when compared to conventional surgical and chemotherapies. This article reviews the current and emerging role of imaging for ablative therapy of renal cell carcinoma.
Literatur
1.
Hock, L.M., J. Lynch, and K.C. Balaji, Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol, 2002. 167(1): p. 57-60.PubMedCrossRef
2.
Lightfoot, N., et al., Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol, 2000. 37(5): p. 521-7.PubMedCrossRef
3.
May, A.M., et al., Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass. Kidney Cancer, 2019. 3: p. 183-188.CrossRef
4.
Wong, M.C.S., et al., Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Scientific Reports, 2017. 7(1): p. 15698.PubMedPubMedCentralCrossRef
5.
Bianchi, M., et al., A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Urol Oncol, 2014. 32(1): p. 46.e1-7.CrossRef
6.
Silverman, S.G., G.M. Israel, and Q.D. Trinh, Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology, 2015. 275(1): p. 28-42.PubMedCrossRef
7.
Lowrance, W.T., et al., Complications after radical and partial nephrectomy as a function of age. The Journal of urology, 2010. 183(5): p. 1725-1730.PubMedPubMedCentralCrossRef
8.
Patel, H.D., et al., Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol, 2017. 12(7): p. 1057-1069.PubMedPubMedCentralCrossRef
9.
Go, A.S., et al., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004. 351(13): p. 1296-305.PubMedCrossRef
10.
Tan, H.J., et al., Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. Jama, 2012. 307(15): p. 1629-35.PubMedCrossRef
11.
Ray, S., J.G. Cheaib, and P.M. Pierorazio, Active Surveillance for Small Renal Masses. Rev Urol, 2020. 22(1): p. 9-16.PubMedPubMedCentral
12.
13.
Volpe, A., The role of active surveillance of small renal masses. Int J Surg, 2016. 36(Pt C): p. 518-524.PubMedCrossRef
14.
Neves, J.B., et al., Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses. BMJ Open, 2019. 9(6): p. e030965.PubMedPubMedCentralCrossRef
15.
Rivero, J.R., et al., Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. J Vasc Interv Radiol, 2018. 29(1): p. 18-29.PubMedCrossRef
16.
Patel, H.D., et al., Comorbidities and causes of death in the management of localized T1a kidney cancer. Int J Urol, 2014. 21(11): p. 1086-92.PubMedCrossRef
17.
Ruhle, A., et al., Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? Clin Transl Radiat Oncol, 2019. 18: p. 104-112.PubMedPubMedCentralCrossRef
18.
Bardin, F., et al., Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: A retrospective study of safety, outcomes and tumor size reduction. Quantitative Imaging in Medicine and Surgery, 2017. 7: p. 8-23.PubMedPubMedCentralCrossRef
19.
Reinhart, H., M. Ghaleb, and B. Davis, Transarterial embolization of renal tumors improves surgical outcomes: A case series. International journal of surgery case reports, 2015. 15: p. 116-118.PubMedPubMedCentralCrossRef
20.
21.
Gunn, A., et al., Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature. Current Urology, 2018. 12: p. 43-49.PubMedPubMedCentralCrossRef
22.
Vikram, R., et al., ACR Appropriateness Criteria Renal Cell Carcinoma Staging. Journal of the American College of Radiology, 2016. 13.
23.
Heilbrun, M., et al., ACR Appropriateness Criteria Indeterminate Renal Mass. J Am Coll Radiol, 2015. 12: p. 333-341.PubMedCrossRef
24.
Hallscheidt, P., et al., Diagnostic Accuracy of Staging Renal Cell Carcinomas Using Multidetector-Row Computed Tomography and Magnetic Resonance Imaging. Journal of computer assisted tomography, 2004. 28: p. 333-9.PubMedCrossRef
25.
Silverman, S.G., et al., Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology, 2019: p. 182646.
26.
Remzi, M., et al., Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol, 2006. 176(3): p. 896-9.PubMedCrossRef
27.
Pahernik, S., et al., Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol, 2007. 178(2): p. 414–7; discussion 416–7.
28.
Schieda, N., et al., Characterization of small (<4cm) solid renal masses by computed tomography and magnetic resonance imaging: Current evidence and further development. Diagnostic and interventional imaging, 2018. 99(7-8): p. 443-455.PubMedCrossRef
29.
Lim, R.S., et al., Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI? Eur Radiol, 2018. 28(2): p. 542-553.PubMedCrossRef
30.
Lum, M., et al., Imaging of Small Renal Masses before and after Thermal Ablation. Radiographics, 2019. 39: p. 190083.CrossRef
31.
Schmit, G., et al., ABLATE: A renal ablation planning algorithm. AJR Am J Roentgenol, 2014. 202: p. 894-903.PubMedCrossRef
32.
McClure, T., et al., Intermediate Outcomes and Predictors of Efficacy in the Radiofrequency Ablation of 100 Pathologically Proven Renal Cell Carcinomas. J Vasc Interv Radiol, 2014. 25.
33.
Camacho, J., et al., R.E.N.A.L. Nephrometry Score Predicts Early Tumor Recurrence and Complications after Percutaneous Ablative Therapies for Renal Cell Carcinoma: A 5-Year Experience. J Vasc Interv Radiol, 2015. 26.
34.
Schmit, G., et al., Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors. The Journal of urology, 2012. 189.
35.
Maxwell, A., et al., Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation. Radiology, 2016. 283: p. 161225.
36.
Abboud, S., et al., Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center. Current Problems in Diagnostic Radiology, 2017. 47.
37.
Gahan, J., et al., The Performance of a Modified RENAL Nephrometry Score in Predicting Renal Mass Radiofrequency Ablation Success. Urology, 2014. 85.
38.
Gupta, A., et al., General Anesthesia and Contrast-Enhanced Computed Tomography to Optimize Renal Percutaneous Radiofrequency Ablation: Multi-Institutional Intermediate-Term Results. Journal of endourology / Endourological Society, 2009. 23: p. 1099-105.CrossRef
39.
Atwell, T.D., et al., Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol, 2012. 23(1): p. 48-54.PubMedCrossRef
40.
Yamanaka, T., et al., CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control. J Vasc Interv Radiol, 2015. 26.
41.
Gervais, D.A., et al., Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol, 2005. 185(1): p. 64-71.PubMedCrossRef
42.
Chen, S.H., et al., Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma. Urology, 2007. 69(5): p. 982 e3-5.PubMedCrossRef
43.
Johnson, D.B., et al., Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology, 2003. 62(2): p. 351-2.PubMedCrossRef
44.
Marion, J., et al., Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation. Journal of Vascular and Interventional Radiology, 2020. 31.
45.
Psutka, S.P., et al., Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol, 2013. 63(3): p. 486-92.PubMedCrossRef
46.
Atwell, T.D., et al., Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol, 2015. 26(6): p. 792-9.PubMedCrossRef
47.
Schmit, G.D., et al., Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. J Endourol, 2010. 24(8): p. 1255-62.PubMedCrossRef
48.
Atwell, T.D., et al., Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol, 2013. 200(2): p. 461-6.PubMedCrossRef
49.
Rosenberg, M., et al., Percutaneous Cryoablation of Renal Lesions With Radiographic Ice Ball Involvement of the Renal Sinus: Analysis of Hemorrhagic and Collecting System Complications. AJR Am J Roentgenol, 2011. 196: p. 935-9.PubMedCrossRef
50.
Janzen, N., et al., "The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model". The Journal of urology, 2005. 173: p. 1368-74.PubMedCrossRef
51.
Schmit, G., et al., Percutaneous Cryoablation of Anterior Renal Masses: Technique, Efficacy, and Safety. AJR Am J Roentgenol, 2010. 195: p. 1418-22.PubMedCrossRef
52.
Boss, A., et al., Thermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication. AJR Am J Roentgenol, 2006. 185: p. 1627-31.CrossRef
53.
Francolini, G., et al., Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature. Crit Rev Oncol Hematol, 2018. 131: p. 24-29.PubMedCrossRef
54.
Siva, S., et al., Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK). International Journal of Radiation Oncology*Biology*Physics, 2020. 108.
55.
Kothari, G., et al., Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases. Chinese Clinical Oncology, 2017. 6: p. 630-630.CrossRef
56.
Grant, S., et al., Stereotactic Body Radiotherapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison with Surgery, Tumor Ablation, and Observation. Advances in Radiation Oncology, 2020. 5.
57.
Correa, R.J.M., et al., The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus, 2019. 5(6): p. 958-969.PubMedCrossRef
58.
Kothari, G., et al., Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review. Acta Oncol, 2015. 54(2): p. 148-57.PubMedCrossRef
59.
Wang, H.Y., et al., Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging, 2012. 12: p. 464-74.PubMedPubMedCentralCrossRef
60.
Pham, D., et al., A Review of Kidney Motion Under Free, Deep and Forced-shallow Breathing Conditions: Implications for Stereotactic Ablative Body Radiotherapy Treatment. Technology in cancer research & treatment, 2013. 13.
61.
Ford, E.C., et al., Respiration-correlated spiral CT: a method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med Phys, 2003. 30(1): p. 88-97.PubMedCrossRef
62.
Rühle, A., et al., Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? Clinical and Translational Radiation Oncology, 2019. 18.
63.
Marconi, L., et al., Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol, 2016. 69(4): p. 660-673.PubMedCrossRef
64.
Richard, P.O., et al., Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience. Eur Urol, 2015. 68(6): p. 1007-13.PubMedCrossRef
65.
Rahbar, H., et al., Evaluation of renal mass biopsy risk stratification algorithm for robotic partial nephrectomy--could a biopsy have guided management? J Urol, 2014. 192(5): p. 1337-42.PubMedCrossRef
66.
Tuncali, K., et al., Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am J Roentgenol, 2004. 183(3): p. 575-82.PubMedCrossRef
67.
Tsang Mui Chung, M.S., et al., Should Renal Mass Biopsy Be Performed prior to or Concomitantly with Thermal Ablation? J Vasc Interv Radiol, 2018. 29(9): p. 1240-1244.CrossRef
68.
Wells, S.A., et al., Renal mass biopsy and thermal ablation: should biopsy be performed before or during the ablation procedure? Abdom Radiol (NY), 2017. 42(6): p. 1773-1780.CrossRef
69.
Widdershoven, C.V., et al., Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up. Abdominal Radiology, 2021. 46(1): p. 373-379.PubMedCrossRef
70.
Finelli, A., et al., Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol, 2017. 35: p. JCO2016699645.CrossRef
71.
Solomon, S. and S. Silverman, Imaging in Interventional Oncology. Radiology, 2010. 257: p. 624-40.PubMedCrossRef
72.
Amalou, H. and B. Wood, Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma. Case reports in urology, 2012. 2012: p. 390912.PubMedPubMedCentralCrossRef
73.
74.
Zhong, J. and T.M. Wah, Renal ablation: current management strategies and controversies. Chinese Clinical Oncology; Vol 8, No 6 (December 2019): Chinese Clinical Oncology (Interventional Oncology), 2019.
75.
O'Neal, D., et al., Contrast-Enhanced Ultrasound-Guided Radiofrequency Ablation of Renal Tumors. Journal of kidney cancer and VHL, 2018. 5: p. 7.PubMedPubMedCentralCrossRef
76.
77.
Curci, N.E., et al., Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation. Eur Radiol, 2021.
78.
Zhu, M., Z. Sun, and C. Ng, Image-guided thermal ablation with MR-based thermometry. Quantitative Imaging in Medicine and Surgery, 2017. 7.
79.
80.
Wile, G., et al., CT and MR Imaging after Imaging-guided Thermal Ablation of Renal Neoplasms1. Radiographics, 2007. 27: p. 325–39; discussion 339.
81.
Kawamoto, S., et al., Sequential Changes after Radiofrequency Ablation and Cryoablation of Renal Neoplasms: Role of CT and MR Imaging1. Radiographics, 2007. 27: p. 343-55.PubMedCrossRef
82.
Levinson, A., et al., Long-Term Oncological and Overall Outcomes of Percutaneous Radio Frequency Ablation in High Risk Surgical Patients With a Solitary Small Renal Mass. The Journal of urology, 2008. 180: p. 499–504; discussion 504.
83.
Johnson, D., et al., Defining the complications of cryoablation and radio frequency ablation of small renal tumors: A multi-institutional review. The Journal of urology, 2004. 172: p. 874-7.PubMedCrossRef
84.
Allen, B. and E. Remer, Percutaneous Cryoablation of Renal Tumors: Patient Selection, Technique, and Postprocedural Imaging 1. Radiographics, 2010. 30: p. 887-900.PubMedCrossRef
85.
Stein, A., et al., Persistent Contrast Enhancement Several Months after Laparoscopic Cryoablation of the Small Renal Mass May Not Indicate Recurrent Tumor. Journal of endourology / Endourological Society, 2008. 22: p. 2433-9.CrossRef
86.
Beemster, P., et al., Follow-Up of Renal Masses After Cryosurgery Using Computed Tomography; Enhancement Patterns and Cryolesion Size. BJU Int, 2008. 101: p. 1237-42.PubMedCrossRef
87.
87.Gill, I., et al., Renal cryoablation: Outcome at 3 years. The Journal of urology, 2005. 173: p. 1903-7.PubMedCrossRef
88.
Goldberg, S., et al., Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria1. J Vasc Interv Radiol, 2005. 16: p. 765-78.PubMedCrossRef
89.
Gervais, D., et al., Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology, 2003. 226 2: p. 417-24.PubMedCrossRef
90.
Zagoria, R., et al., Oncologic Efficacy of CT-Guided Percutaneous Radiofrequency Ablation of Renal Cell Carcinomas. AJR Am J Roentgenol, 2007. 189: p. 429-36.PubMedCrossRef
91.
92.
Schmit, G., et al., Ice Ball Fractures during Percutaneous Renal Cryoablation: Risk Factors and Potential Implications. J Vasc Interv Radiol, 2010. 21: p. 1309-12.PubMedCrossRef
93.
Gervais, D., et al., Radiofrequency Ablation of Renal Cell Carcinoma: Part 2, Lessons Learned with Ablation of 100 Tumors. AJR Am J Roentgenol, 2005. 185: p. 72-80.PubMedCrossRef
94.
Uppot, R., et al., Imaging-Guided Percutaneous Ablation of Renal Cell Carcinoma: A Primer of How We Do It. AJR Am J Roentgenol, 2009. 192: p. 1558-70.PubMedCrossRef
95.
El Dib, R., N.J. Touma, and A. Kapoor, Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int, 2012. 110(4): p. 510-6.PubMedCrossRef
96.
Kurup, A., et al., Neuroanatomic Considerations in Percutaneous Tumor Ablation. Radiographics, 2013. 33: p. 1195-1215.PubMedCrossRef
97.
Park, B. and C.K. Kim, Complications of image-guided radiofrequency ablation of renal cell carcinoma: Causes, imaging features and prevention methods. Eur Radiol, 2009. 19: p. 2180-90.PubMedCrossRef
98.
Hui, G., et al., Comparison of Percutaneous and Surgical Approaches to Renal Tumor Ablation: Metaanalysis of Effectiveness and Complication Rates. J Vasc Interv Radiol, 2008. 19: p. 1311-20.PubMedCrossRef
99.
Ginat, D. and W. Saad, Bowel Displacement and Protection Techniques During Percutaneous Renal Tumor Thermal Ablation. Tech Vasc Interv Radiol, 2010. 13: p. 66-74.PubMedCrossRef
100.
Maas, M., et al., Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice. Insights into imaging, 2020. 11.
101.
Kielar, A., R. Hibbert, and K. Maturen, Imaging after Local Tumor Therapies: Kidney and Liver. Seminars in roentgenology, 2013. 48: p. 273-284.PubMedCrossRef
102.
Matsumoto, E., et al., The radiographic evolution of radio frequency ablated renal tumors. The Journal of urology, 2004. 172: p. 45-8.PubMedCrossRef
103.
Schirmang, T., et al., Kidney Neoplasms: Renal Halo Sign after Percutaneous Radiofrequency Ablation—Incidence and Clinical Importance in 101 Consecutive Patients 1. Radiology, 2009. 253: p. 263-9.PubMedCrossRef
104.
Kawamoto, S., et al., Computed Tomography and Magnetic Resonance Imaging Appearance of Renal Neoplasms After Radiofrequency Ablation and Cryoablation. Seminars in ultrasound, CT, and MR, 2009. 30: p. 67-77.PubMedPubMedCentralCrossRef
105.
Remer, E., et al., MR Imaging of the Kidneys After Laparoscopic Cryoablation. AJR Am J Roentgenol, 2000. 174: p. 635-40.PubMedCrossRef
106.
107.
Park, S.Y., C.K. Kim, and B. Park, Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas. European journal of radiology, 2013. 83.
108.
Gervais, D., et al., Radio-frequency Ablation of Renal Cell Carcinoma: Early Clinical Experience1. Radiology, 2000. 217: p. 665-72.PubMedCrossRef
109.
Zagoria, R., et al., Percutaneous CT-Guided Radiofrequency Ablation of Renal Neoplasms: Factors Influencing Success. AJR Am J Roentgenol, 2004. 183: p. 201-7.PubMedCrossRef
110.
Varkarakis, I., et al., Percutaneous radio frequency ablation of renal masses: Results at a 2-year mean followup. The Journal of urology, 2005. 174: p. 456–60; discussion 460.
111.
Hussein, D., et al., Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift? Journal of Vascular and Interventional Radiology, 2017. 28.
112.
Matin, S., et al., Residual and Recurrent Disease Following Renal Energy Ablative Therapy: A Multi-Institutional Study. The Journal of urology, 2006. 176: p. 1973-7.PubMedCrossRef
113.
Eiken, P.W., et al., Imaging following renal ablation: what can we learn from recurrent tumors? Abdom Radiol (NY), 2018. 43(10): p. 2750-2755.CrossRef
114.
Takaki, H., et al., False-Positive Tumor Enhancement After Cryoablation of Renal Cell Carcinoma: A Prospective Study. AJR Am J Roentgenol, 2016. 206(2): p. 332-9.PubMedCrossRef
115.
Lokken, R.P., et al., Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol, 2007. 189(4): p. 845-8.PubMedCrossRef
116.
Iguchi, T., et al., Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma. Diagn Interv Imaging, 2016. 97(11): p. 1159-1164.PubMedCrossRef
117.
118.
Sun, M.R., et al., Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. AJR Am J Roentgenol, 2016. 206(3): p. 544-53.PubMedPubMedCentralCrossRef
119.
Siva, S., et al., A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int, 2012. 110(11 Pt B): p. E737–43.
120.
Funayama, S., et al., Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy. Technol Cancer Res Treat, 2019. 18: p. 1533033818822329.PubMedPubMedCentralCrossRef
121.
Nair, V.J., et al., CyberKnife for inoperable renal tumors: Canadian pioneering experience. Can J Urol, 2013. 20(5): p. 6944-9.PubMed
122.
Ponsky, L., et al., Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma. Radiother Oncol, 2015. 117(1): p. 183-7.PubMedCrossRef
123.
Chang, J.H., et al., Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience. Clin Oncol (R Coll Radiol), 2016. 28(9): p. e109-14.CrossRef
124.
Kaidar-Person, O., et al., Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma. Clin Genitourin Cancer, 2017. 15(5): p. e851-e854.PubMedCrossRef
125.
Reynolds, H.M., et al., Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma. PLoS One, 2018. 13(8): p. e0202387.PubMedPubMedCentralCrossRef
126.
127.
Capitanio, U., et al., Epidemiology of Renal Cell Carcinoma. Eur Urol, 2019. 75(1): p. 74-84.PubMedCrossRef
128.
Choueiri, T.K. and R.J. Motzer, Systemic Therapy for Metastatic Renal-Cell Carcinoma. N Engl J Med, 2017. 376(4): p. 354-366.PubMedCrossRef
129.
Zhang, Y., et al., Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. Int J Radiat Oncol Biol Phys, 2019. 105(2): p. 367-375.PubMedPubMedCentralCrossRef
130.
131.
Dabestani, S., et al., Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol, 2014. 15(12): p. e549-61.PubMedCrossRef
132.
Motzer, R.J., et al., NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. J Natl Compr Canc Netw, 2019. 17(11): p. 1278-1285.PubMedCrossRef
133.
Bang, H.J., et al., Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol, 2012. 23(6): p. 770-7.PubMedCrossRef
134.
Welch, B.T., et al., Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol, 2014. 192(2): p. 357-63.PubMedCrossRef
135.
Gardner, C.S., et al., Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control. J Bone Joint Surg Am, 2017. 99(22): p. 1916-1926.PubMedCrossRef
136.
Clark, T.W., et al., Reporting standards for percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol, 2009. 20(7 Suppl): p. S409-16.PubMedCrossRef
137.
Gonnet, A., et al., Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience. BMC Cancer, 2019. 19(1): p. 1182.PubMedPubMedCentralCrossRef
138.
Carrafiello, G., et al., Current role of interventions in metastatic kidney tumors: single center experience. Updates Surg, 2011. 63(4): p. 259-69.PubMedCrossRef
139.
Zimmermann, M., C. Kuhl, and S. Keil, Characteristic changes of the ablation zone on contrast-enhanced computed tomography after radiofrequency ablation of hepatic metastases. Indian J Radiol Imaging, 2018. 28(3): p. 320-326.PubMedPubMedCentralCrossRef
140.
141.
Ahmed, M. and R. Technology Assessment Committee of the Society of Interventional, Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. J Vasc Interv Radiol, 2014. 25(11): p. 1706-8.PubMedCrossRef
142.
Elias, D., et al., Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol, 2004. 30(1): p. 85-7.PubMedCrossRef
143.
Zaorsky, N.G., et al., Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies. Eur Urol Oncol, 2019. 2(5): p. 515-523.PubMedCrossRef
144.
Marvaso, G., et al., Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how? Clin Transl Oncol, 2021.
145.
Buti, S., et al., Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study. Cancer Treat Res Commun, 2020. 22: p. 100161.PubMedCrossRef
146.
Wang, C.J., et al., Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases. Int J Radiat Oncol Biol Phys, 2017. 98(1): p. 91-100.PubMedPubMedCentralCrossRef
147.
Grunwald, V., et al., An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma. Nat Rev Urol, 2018. 15(8): p. 511-521.PubMedPubMedCentralCrossRef
148.
Filippiadis, D., et al., Percutaneous ablation techniques for renal cell carcinoma: current status and future trends. Int J Hyperthermia, 2019. 36(2): p. 21-30.PubMedCrossRef
149.
Ahmed, M., et al., Principles of and advances in percutaneous ablation. Radiology, 2011. 258(2): p. 351-69.PubMedCrossRef
150.
Takaki, H., et al., Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol, 2010. 28(6): p. 460-8.PubMedCrossRef
151.
Wah, T.M., et al., Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int, 2014. 113(3): p. 416-28.PubMedCrossRef
152.
Zagoria, R.J., et al., Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology, 2011. 77(6): p. 1393-7.PubMedCrossRef
153.
Ma, Y., et al., Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int, 2014. 113(1): p. 51-5.PubMedCrossRef
154.
Tracy, C.R., et al., Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer, 2010. 116(13): p. 3135-42.PubMedCrossRef
155.
Thompson, R.H., et al., Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol, 2015. 67(2): p. 252-9.PubMedCrossRef
156.
Andrews, J.R., et al., Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol, 2019. 76(2): p. 244-251.PubMedCrossRef
157.
Carrafiello, G., et al., Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg, 2008. 6 Suppl 1: p. S65-9.PubMedCrossRef
158.
Simon, C.J., D.E. Dupuy, and W.W. Mayo-Smith, Microwave ablation: principles and applications. Radiographics, 2005. 25 Suppl 1: p. S69-83.PubMedCrossRef
159.
160.
Wah, T.M., Image-guided ablation of renal cell carcinoma. Clin Radiol, 2017. 72(8): p. 636-644.PubMedCrossRef
161.
Yu, J., et al., US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology, 2012. 263(3): p. 900-8.PubMedCrossRef
162.
Yu, J., et al., Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma. Abdom Imaging, 2015. 40(8): p. 3248-56.PubMedCrossRef
163.
Li, X., et al., Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma. Radiol Oncol, 2013. 47(4): p. 398-404.PubMedPubMedCentralCrossRef
164.
Ierardi, A.M., et al., Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications. Med Oncol, 2017. 34(5): p. 97.PubMedCrossRef
165.
Chan, P., et al., Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up. Clin Radiol, 2017. 72(9): p. 786-792.PubMedCrossRef
166.
Klapperich, M.E., et al., Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study. Radiology, 2017. 284(1): p. 272-280.PubMedCrossRef
167.
Lagerveld, B.W., Cryosurgical induced injury of human cancerous tissues – How it works? British Journal of Medical and Surgical Urology, 2012. 5: p. S24-S27.CrossRef
168.
Dominguez-Escrig, J.L., K. Sahadevan, and P. Johnson, Cryoablation for small renal masses. Adv Urol, 2008: p. 479495.
169.
Georgiades, C., et al., Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol, 2013. 36(3): p. 783-90.PubMedCrossRef
170.
Maybody, M., et al., Pneumodissection for skin protection in image-guided cryoablation of superficial musculoskeletal tumours. Eur Radiol, 2016. 27.
171.
Autorino, R. and J.H. Kaouk, Cryoablation for small renal tumors: current status and future perspectives. Urol Oncol, 2012. 30(4 Suppl): p. S20-7.PubMedCrossRef
172.
Sahgal, A., et al., The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 2012. 24: p. 629-39.PubMedCrossRef
173.
Swaminath, A. and W. Chu, Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2015. 9: p. 275-80.PubMedPubMedCentralCrossRef
174.
Siva, S., et al., Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK): Pooled Analysis of SABR for Primary RCC. Cancer, 2017. 124.
Metadaten
Titel
Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma
verfasst von
Mohammad Haroon
Paul Sathiadoss
Rebecca M. Hibbert
Satheesh Krishna Jeyaraj
Christopher Lim
Nicola Schieda
Publikationsdatum
10.07.2021
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 11/2021
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03178-6

Weitere Artikel der Ausgabe 11/2021

Abdominal Radiology 11/2021 Zur Ausgabe

Correction

Correction to: Diagnostic performance of preoperative MR imaging findings for differentiation of uterine leiomyoma with intraligamentous growth from subserosal leiomyoma

Correction

Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression

Hepatobiliary

Dual-energy computed tomography for non-invasive prediction of the risk of oesophageal variceal bleeding with hepatitis B cirrhosis

Hepatobiliary

Systematic review and meta-analysis of diagnostic performance of CT imaging for assessing resectability of pancreatic ductal adenocarcinoma after neoadjuvant therapy: importance of CT criteria

Review

Imaging of Kaposi sarcoma

Kidneys, Ureters, Bladder, Retroperitoneum

MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise